Basic clinical features of the 218 chronic hepatitis B patients analysed by logistic regression
| Patients (n) | 218 | |
| Follow-up duration (years) | Total person-years | 1107.48 |
| Average/SD | 5.08/2.24 | |
| Median | 4.57 | |
| Max | 15.06 | |
| Minimum | 1.51 | |
| Sex, n (%) | Male | 152 (69.7) |
| Female | 66 (30.3) | |
| Age (years) | Mean (SD) | 46.05 (11.92) |
| Age (years) distribution, n (%) | <30 | 22 (10.09) |
| 30–40 | 51 (23.39) | |
| 40–50 | 59 (27.06) | |
| 50–60 | 59 (27.06) | |
| >60 | 27 (12.39) | |
| E seroconversion | HBeAg negative or HBeAb positive | 167 (76.61) |
| HBeAg positive and HBeAb negative | 51 (23.39) | |
| BMI* (kg/m2) | Mean (SD) | 24.72 (3.84) |
| <18.5, n (%) | 6 (2.75) | |
| 18.5 to <25, n (%) | 119 (54.59) | |
| 25.0 to <30, n (%) | 76 (34.86) | |
| 30.0 or higher, n (%) | 17 (7.80) | |
| Initial FIB-4 index | Mean | 1.36 |
| SD | 1.10 | |
| Median | 1.08 | |
| Last FIB-4 index | Mean | 1.41 |
| SD | 0.93 | |
| Median | 1.24 | |
*The BMI is the weight in kilograms divided by the square of height in metres.
BMI, body mass index; FIB-4, Fibrosis-4 Index; HBeAb, hepatitis B antibody; HBeAg, hepatitis B e antigen.